Search

Home > This Week in Machine Learning & Artificial Intelligence (AI) Podcast > Machine Learning: A New Approach to Drug Discovery with Daphne Koller - #332
Podcast: This Week in Machine Learning & Artificial Intelligence (AI) Podcast
Episode:

Machine Learning: A New Approach to Drug Discovery with Daphne Koller - #332
Category: Technology
Duration: 00:43:40
Publish Date: 2019-12-26 12:41:47
Description:

Today we continue our 2019 NeurIPS coverage joined by Daphne Koller, co-Founder and former co-CEO of Coursera and Founder and CEO of Insitro. We caught up with Daphne to discuss: 

  • Her background in machine learning, beginning in ‘93, and her work with the Stanford online machine learning courses, and eventually her work at Coursera.
  • The current landscape of pharmaceutical drug discovery, including the current pricing of drugs and misnomers with why drugs are so expensive, 
  • Her work at Insitro, a company looking to advance drug discovery and development with machine learning. 
  • An overview of Insitro’s goal of using ML as a “compass” in drug discovery. 
  • How Insitro functions as a company in this space, including their focus on the biology of drug discovery and the landscape of ML techniques being used
  • Daphne’s thoughts on AutoML, and much more!

The full show notes for this episode can be found at twimlai.com/talk/332. Make sure you head over to twimlai.com/neurips2019 to follow along with this series!
Total Play: 0